Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

NCT04804514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Dentin Sensitivity

Interventions

DRUG: KH001
DRUG: Placebo

Sponsor

HysensBio Co., Ltd